Finance entity
All 2 tracked stories fall under one category: earnings. Rigel Pharmaceuticals is most often covered alongside A.J. Kazimi, which appears in 1 of these 2 stories. At 5, the average consequence score sits below the same-window beat average of 6.1.
Last mentioned: Mar 5, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 2 tracked stories fall under one category: earnings. Rigel Pharmaceuticals is most often covered alongside A.J. Kazimi, which appears in 1 of these 2 stories. At 5, the average consequence score sits below the same-window beat average of 6.1. Each story carries 2 original sources on average, compared with 2.7 for the broader beat in this window. We currently track 2 Finance stories that mention Rigel Pharmaceuticals, published between March 2, 2026 and March 5, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 242 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Rigel Pharmaceuticals. Shared-story counts are live from our verified record — not editorial picks.
Cumberland and Rigel Pharmaceuticals reported Q4 2025 results, highlighting strategic shifts toward high-margin specialty products and oncology expansions. While Cumberland focuses on hospital-channel optimization, Rigel is doubling down on its hematology-oncology portfolio to drive long-term growth.
Arcturus Therapeutics and Rigel Pharmaceuticals are preparing to report Q4 2025 results, highlighting a pivotal shift from clinical development to commercial execution. Investors are focused on Arcturus's mRNA vaccine rollout in Japan and Rigel's integration of its expanded oncology portfolio.
Rigel Pharmaceuticals is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
